CVS241018P75000
- 10.15
- +0.30+3.05%
CVS Health Newsroom
Income Investing: 6 Dividend Stocks to Buy After Tax-Loss Season -- Barron's
TD Cowen Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $85
Truist Financial Maintains CVS Health(CVS.US) With Buy Rating, Announces Target Price $76
6 Dividend Stocks to Buy -- Once Tax-Loss Season Is Over -- Barrons.com
CVS Health Analyst Ratings
Barclays Upgrades CVS Health(CVS.US) to Buy Rating, Raises Target Price to $82
CVS Health Is Maintained at Outperform by Evercore ISI Group
CVS Health Analyst Ratings
Evercore Maintains CVS Health(CVS.US) With Buy Rating, Raises Target Price to $75
CVS Health Upgraded to Buy From Hold at TD Cowen
CVS Health Upgraded, Mobileye Downgraded: Wall Street's Top Analyst Calls
CVS Stock Can Gain 35% From Here, Analyst Says. Here's How. -- Barrons.com
CVS Health Analyst Ratings
TD Cowen Upgrades CVS Health(CVS.US) to Buy Rating, Raises Target Price to $85
TD Cowen Upgrades CVS Health to Buy From Hold, Adjusts Price Target to $85 From $59
Buy Rating on CVS Health: Strategic MA Plan Benefits and Anticipated Double-Digit EPS Growth
Mizuho Securities Maintains CVS Health(CVS.US) With Buy Rating, Cuts Target Price to $66
A Quick Look at Today's Ratings for CVS Health(CVS.US), With a Forecast Between $63 to $77
CVS Health Analyst Ratings
Bank of America Securities Remains a Buy on CVS Health (CVS)